Medical News

RSS

Employers may not restore benefits to pre-recession levels

"Since the downturn began, thousands of employers have cut pay, increased workers' share of health-care costs or reduced the employer contribution to retirement plans," The Wall Street Journal reports.

21 Oct 2009

Inovio Biomedical highlights its advances in SynCon DNA vaccines

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio’s Scientific Advisory Board, highlighted advances in electroporation-delivered SynCon™ DNA vaccines compared to other leading vaccine technologies at the AIDS Vaccine 2009 Conference being held this week in Paris, France.

21 Oct 2009

New research highlights brain's vulnerability to obesity

New research released today is affirming a long-held maxim: you are what you eat - and, more to the point, what you eat has a profound influence on the brain. The findings offer insight into the neurobiological factors behind the obesity epidemic in the United States and other developed countries.

20 Oct 2009

New EHR and practice management solution from Nuesoft Technologies

Nuesoft Technologies Inc. today announced the launch of its electronic health record (EHR). The NueMD® EHR 5.2 is certified for Ambulatory EHR 2007 by the Certification Commission for Health Information Technology (CCHIT®), and accompanies NueMD's medical practice management software solution to comprise NueMD® Complete, a fully integrated practice management and electronic medical record.

20 Oct 2009

Computerized decision support solution from GE Healthcare

As part of GE’s healthymagination commitment, GE Healthcare today announced a new solution that puts clinical data and treatment practices in the hands of doctors and clinicians in real-time so that they can make informed decisions right at the point of care.

20 Oct 2009

U.S. patent for Celsis IVT's LiverPool products

Celsis International is pleased to announce that the United States Patent and Trademark Office today issued U.S. Patent No. 7,604,929 to Celsis In Vitro Technologies (Celsis IVT). This patent generally covers processes by which the company creates its unique LiverPool(TM) products for drug discovery research.

20 Oct 2009

World Medical Association adopts climate change, task shifting resolutions

At its general assembly in New Delhi, India, the World Medical Association (WMA), "a conglomerate of medical associations around the world," approved a plan that aims "to minimise the risk of increased malnutrition deaths, diseases and injuries due to climate change," IANS/Thaindian News reports (10/17).

20 Oct 2009

White House rallies support for health care bills; relationship with Chamber Of Commerce sours

Today, "President Obama will speak from New York City by video hookup to hundreds of small gatherings sponsored by Organizing for America, a spinoff of his 2008 campaign," USA Today reports

20 Oct 2009

Study: Working during retirement is good for your health

A new study suggests that working full-time or part-time during retirement may be beneficial to your health, The New York Times reports.

20 Oct 2009

Patients with chronic hepatitis C can benefit by drinking coffee

Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).

20 Oct 2009

By protecting doctors' Medicare pay, lawmakers look to keep health reform tab low

The Los Angeles Times reports on a Democratic plan to cancel scheduled cuts to physician pay under the Medicare program with a bill separate from their sweeping health reform proposal. It would allow lawmakers to "reconcile a nearly $250-billion difference between the House and Senate" while at the same time keeping the American Medical Association on board with their plans.

20 Oct 2009

Covalon and Bard sign license agreement; Bard to apply Covalon's technology on its products

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSX VENTURE:COV), an advanced medical products company, announced that it has signed a License Agreement as well as a Services and Supply Agreement with a division of C. R. Bard, Inc.

20 Oct 2009

IPS examines potential for future U.N. population meeting

Inter Press Service examines the possibility of another U.N. conference on development and population within the next five years. Despite progress made since the 1994 conference on population and development (ICPD), U.N. Secretary-General Ban Ki-Moon recently noted more than 200 million women cannot access safe and effective contraception, and "too many women resort to unsafe abortions because they lack access to family planning," according to the news service.

20 Oct 2009

As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease

Experts, gathered for the start of a four-day conference on HIV vaccines in Paris, called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.

20 Oct 2009

Eclipsys supports healthcare providers to meet the goal of ARRA

To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today.

20 Oct 2009

On-line portal for training doctors and nurses on fall prevention and protection

Medical Nurse Training, Inc. (www.MedicalNurseTraining.com) is the premier on-line portal for training doctors and nurses on fall prevention and protection.

20 Oct 2009

Positive results from KAI Pharmaceuticals' pain therapeutic program

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced positive preclinical results from its program targeting the gamma protein kinase C (PKC) pathway for the development of novel therapies for pain.

20 Oct 2009

Tarsa Therapeutics receives license for Phase III oral calcitonin program

Unigene Laboratories, Inc. and Tarsa Therapeutics, Inc. today announced that Unigene has licensed its Phase III oral calcitonin program to Tarsa, a new company formed by a syndicate of three venture capital funds specializing in the life sciences: MVM Life Science Partners, Quaker BioVentures and Novo A/S.

20 Oct 2009

Children having accelerated bone growth at an increased risk of hypertension

Children whose bones are "older" than their chronological age may be at an increased risk of hypertension, according to a study reported today (19 October) in Hypertension: Journal of the American Heart Association.

20 Oct 2009

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

BioSante Pharmaceuticals, Inc., today announced positive safety data in its ongoing LibiGel Phase III clinical development program. For the first time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review of unblinded data, the DMC unanimously recommended continuation of the study as described in the study protocol, with no modifications.

20 Oct 2009